Integration of genomic data into electronic health records

Similar documents
Electronic Medical Records and Genomics: Possibilities, Realities, Ethical Issues to Consider

Genomics and Health Data Standards: Lessons from the Past and Present for a Genome-enabled Future

The Future of the Electronic Health Record. Gerry Higgins, Ph.D., Johns Hopkins

An EVIDENCE-ENHANCED HEALTHCARE ECOSYSTEM for Cancer: I/T perspectives

SAP Healthcare Analytics Solutions Provide physicians and researchers access to patient data from various systems in realtime

Genomic CDS: an example of a complex ontology for pharmacogenetics and clinical decision support

Genomics and the EHR. Mark Hoffman, Ph.D. Vice President Research Solutions Cerner Corporation

Clinical Implementation of Psychiatric Pharmacogenomic Testing

Integration of Genetic and Familial Data into. Electronic Medical Records and Healthcare Processes

Implementation of Pharmacogenomics in Clinical Practice: Barriers and Potential Solutions

Outcome Data, Links to Electronic Medical Records. Dan Roden Vanderbilt University

Essential Nursing Competencies and Curricula Guidelines for Genetics and Genomics: Outcome Indicators

Vision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision

#Aim2Innovate. Share session insights and questions socially. Genomics, Precision Medicine and the EHR 6/17/2015

Personalized Medicine: Humanity s Ultimate Big Data Challenge. Rob Fassett, MD Chief Medical Informatics Officer Oracle Health Sciences

Genetic testing. The difference diagnostics can make. The British In Vitro Diagnostics Association

14.3 Studying the Human Genome

What is Pharmacogenomics? Personalization of Medications for You! Michigan State Medical Assistants Conference May 6, 2006

Delivering the power of the world s most successful genomics platform

Enhancing Functionality of EHRs for Genomic Research, Including E- Phenotying, Integrating Genomic Data, Transportable CDS, Privacy Threats

Integrating Bioinformatics, Medical Sciences and Drug Discovery

Leading Genomics. Diagnostic. Discove. Collab. harma. Shanghai Cambridge, MA Reykjavik

SMART-on-FHIR Genomics: Enabling Precision Medicine by Bridging Clinical and Genomic Information

SNPbrowser Software v3.5

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE E15

SAP HANA Enabling Genome Analysis

Global Alliance. Ewan Birney Associate Director EMBL-EBI

The National Institute of Genomic Medicine (INMEGEN) was

BIOINF 525 Winter 2016 Foundations of Bioinformatics and Systems Biology

How To Change Medicine

Clinical Implementation of. Pharmacist-Managed Service. Kristine R. Crews, Pharm.D., BCPS St. Jude Children s Research Hospital

Bench to Bedside Clinical Decision Support:

Chapter 8: Recombinant DNA 2002 by W. H. Freeman and Company Chapter 8: Recombinant DNA 2002 by W. H. Freeman and Company

Genetic diagnostics the gateway to personalized medicine

ITT Advanced Medical Technologies - A Programmer's Overview

A leader in the development and application of information technology to prevent and treat disease.

Reduced Risk & Improved Efficacy through Integrated Pharmacogenetics

The Spectrum of Biomedical Informatics and the UAB Informatics Institute

Lecture 6: Single nucleotide polymorphisms (SNPs) and Restriction Fragment Length Polymorphisms (RFLPs)

Vad är bioinformatik och varför behöver vi det i vården? a bioinformatician's perspectives

Personalized medicine in China s healthcare system

A Pilot Study of the Incidence of Exposure to Drugs for which Preemptive Pharmacogenomic Testing Is Available

European Genome-phenome Archive database of human data consented for use in biomedical research at the European Bioinformatics Institute

ORACLE HEALTH SCIENCES INFORM ADVANCED MOLECULAR ANALYTICS

Digital Health: Catapulting Personalised Medicine Forward STRATIFIED MEDICINE

How Can Institutions Foster OMICS Research While Protecting Patients?

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America

Implementation Guide for CDA Release 2 Genetic Testing Report (GTR)

Health Informatics Research and Development in Europe

Building open source safety-critical medical device platforms and Meaningful Use EHR gateways

Worldwide Collaborations in Molecular Profiling

Workshop on Establishing a Central Resource of Data from Genome Sequencing Projects

A Primer of Genome Science THIRD

Health Information Technology: Introduction to One Key Part - the EHR

Revision of the Directive 98/79/EC on In Vitro Diagnostic Medical Devices. Response from Cancer Research UK to the Commission August 2010

(1-p) 2. p(1-p) From the table, frequency of DpyUnc = ¼ (p^2) = #DpyUnc = p^2 = ¼(1-p)^2 + ½(1-p)p + ¼(p^2) #Dpy + #DpyUnc

Clinical Decision Support Systems. Dr. Adrian Mondry

DNA Sequencing and Personalised Medicine

Distance Education and Learning for Medical Imaging Informatics

How To Use Data Analysis To Get More Information From A Computer Or Cell Phone To A Computer

Accreditation of Master of Pharmacy Degrees

Presenting data: how to convey information most effectively Centre of Research Excellence in Patient Safety 20 Feb 2015

EMR Adoption Survey. Instructions. This survey contains a series of multiple-choice questions corresponding to the 5-stage EMR Adoption Model.

Lessons from the Stanford HIV Drug Resistance Database

Core Facility Genomics

Regulatory Issues in Genetic Testing and Targeted Drug Development

Roche Diagnostics Driving Personalized Healthcare

PREDICTIVE ANALYTICS: PROVIDING NOVEL APPROACHES TO ENHANCE OUTCOMES RESEARCH LEVERAGING BIG AND COMPLEX DATA

Introduction to genetic testing and pharmacogenomics

The Do s and Don ts of Medical Device integration

Overview of Genetic Testing and Screening

Big Data in Healthcare: Current Possibilities and Emerging Opportunities

BIG DATA, BIOBANKS AND PREDICTIVE ANALYTICS FOR A BETTER CLINICAL OUTCOME

A Tech Entrepreneur Meets Academic Pathology

IBM Watson and Medical Records Text Analytics HIMSS Presentation

OME : Mobile Cognitive Healthcare for the Consumer. Michael Nova, M.D. Chief Innovation Officer Pathway Genomics

HOW WILL BIG DATA AFFECT RADIOLOGY (RESEARCH / ANALYTICS)? Ronald Arenson, MD

Reimbursement for Molecular Diagnostics

Developing VA GDx: An Informatics Platform to Capture and Integrate Genetic Diagnostic Testing Data into the VA Electronic Medical Record

MED 2400 MEDICAL INFORMATICS FUNDAMENTALS

PUBLISHED BY: CareCloud Corporation 5200 Blue Lagoon Drive, Suite 900 Miami, FL Phone: (877)

Big Data for Population Health and Personalised Medicine through EMR Linkages

Transcription:

Integration of genomic data into electronic health records Daniel Masys, MD Affiliate Professor Biomedical & Health Informatics University of Washington, Seattle

Major portion of today s lecture is based on this article, currently in press and available online at http://www.ncbi.nlm.nih.gov/pubmed/22223081

Topics Context: Systems design issues in Healthcare Functional characteristics of an ideal system A prototype operational EHR with genomic decision support

Systems Design Issues in Healthcare Current practice largely depends upon the clinical decision making capacity and reliability of autonomous individual practitioners, for classes of problems that routinely exceed the bounds of unaided human cognition

The molecular tsunami crashes on the beach of human cognitive capacity for decision making Facts per Decision 1000 100 Proteomics and other effector molecules Functional Genetics: Gene expression profiles Decisions by clinical phenotype i.e., traditional health care 10 1990 2000 2010 2020 Structural Genetics: e.g. SNPs, haplotypes Human Cognitive Capacity

7 desiderata for molecular variation data in EHRs 1. Lossless data compression from (high volume) primary observations to clinically relevant subsets. Issue: current practice by clinical laboratories extinguishes many observations not felt to be clinically relevant.

7 desiderata for molecular variation data in EHRs 1. Lossless data compression from (high volume) primary observations to clinically relevant subsets. 2. Since methods will change, molecular lab results carry observation methods with them (LOINC model) Issue: Methods used to perform genetic assays normally embedded in PDF text report but not available as structured data.

7 desiderata for molecular variation data in EHRs 1. Lossless data compression from (high volume) primary observations to clinically relevant subsets. 2. Since methods will change, molecular lab results carry observation methods with them (LOINC model) 3. Compact representation of clinically actionable subsets for optimal performance (clinician thinkspeed = 250msec) Issue: Using keywords and short phrases e.g., CYP2C19*2*2 as shorthand for presence of CYP2C19 homozygous variant that poorly metabolizes commonly prescribed drugs such as Clopidigrel (Plavix) enables quick visual recognition and efficient lookup by decision support rules. Currently << 1% of complete genome.

7 desiderata for molecular variation data in EHRs 1. Lossless data compression from (high volume) primary observations to clinically relevant subsets. 2. Since methods will change, molecular lab results carry observation methods with them (LOINC model) 3. Compact representation of clinically actionable subsets for optimal performance (clinician thinkspeed = 250msec) 4. Simultaneously support for human-viewable formats (with links to interpretation) and formats interpretable by decision support rules. Issue: Volume and complexity of molecular variation data exceeds cognitive capacity even of specialists. Genomic competence rare among primary care providers.

7 desiderata for molecular variation data in EHRs 1. Lossless data compression from (high volume) primary observations to clinically relevant subsets. 2. Since methods will change, molecular lab results carry observation methods with them (LOINC model) 3. Compact representation of clinically actionable subsets for optimal performance (clinician thinkspeed = 250msec) 4. Simultaneously support for human-viewable formats (with links to interpretation) and formats interpretable by decision support rules. 5. Separate primary sequence data (remain true if accurate) from clinical interpretations of them (will change with rapidly changing science) Issue: Data plus interpretation in narrative lab report document is the most common current format for transmitting results back to clinicians.

Most common current method for delivery of DNA analysis into clinical operations

7 desiderata for molecular variation data in EHRs 1. Lossless data compression from (high volume) primary observations to clinically relevant subsets. 2. Since methods will change, molecular lab results carry observation methods with them (LOINC model) 3. Compact representation of clinically actionable subsets for optimal performance (clinician thinkspeed = 250msec) 4. Simultaneously support for human-viewable formats (with links to interpretation) and formats interpretable by decision support rules. 5. Separate primary sequence data (remain true if accurate) from clinical interpretations of them (will change with rapidly changing science) 6. Anticipate the boundless creativity of Nature: multiple somatic genomes, multiple germline genomes for each individual over their lifetime.

7 desiderata for molecular variation data in EHRs 1. Lossless data compression from (high volume) primary observations to clinically relevant subsets. 2. Since methods will change, molecular lab results carry observation methods with them (LOINC model) 3. Compact representation of clinically actionable subsets for optimal performance (clinician thinkspeed = 250msec) 4. Simultaneously support for human-viewable formats (with links to interpretation) and formats interpretable by decision support rules. 5. Separate primary sequence data (remain true if accurate) from clinical interpretations of them (will change with rapidly changing science) 6. Anticipate the boundless creativity of Nature: multiple somatic genomes, multiple germline genomes for each individual over their lifetime. 7. Support both individual care and discovery science

Intrepretations of primary data (expect rapid change) Primary Observations. If accurate, keep forever Structured keywords for clinical decision support (e.g., C*2*2CLM fires decision rule for CYP2C19*2 homozygotes at time of clopidigrel prescribing). A few tens of bytes each. Layered classes of EHR-relevant data Interpretive codes Diagnostic Interpretations (PDF reports). A few kilobytes each. Personal molecular differences represented in EHR as computed offset from a Clinical Standard Reference Genome (CSRG) =~1% of genome/ proteome. A few megabytes. Consensus full personal germline and somatic sequence(s) and metadata: a few gigabytes each 8x -30x nextgen reads: hundreds of gigabytes/terabyte

Characteristics of a Clinical Standard Reference Genome (CSRG) Should generate the smallest number of differences to be stored in the EHR. (Simplest approach: most common allele for all known genes) Should *not* represent any actual person, ethnic group, family ancestry to avoid arguments based on those characteristics Should be accompanied by decompression/recompression utilities to rapidly transform any given individual s genome or subset of it. Subject to version control: expect many different CSRGs as sequencing technology improves.

Putting it all together in an operational healthcare prototype

PREDICT: Pharmacogenomic Resource for Enhanced Decisions in Care and Therapy (Go-live date: Sept 15, 2010) Use data mining methods in Electronic Medical Record (EMR) to identify individuals at increased likelihood of a future prescription of a drug for which pharmacogenetics has relevance Prospectively acquire 200 marker SNP panel and put selected subset of data in electronic medical record At moment of prescribing, use decision support rules that look for presence of pharmacogenetic keywords e.g., CYP2C19xxxx to guide drug selection and correct dosing. Track outcomes

Point of care decision support

Clinician display

The face of personalized medicine

Intrepretations of primary data (expect rapid change) Primary Observations. If accurate, keep forever Structured keywords for clinical decision support (e.g., C*2*2CLM fires decision rule for CYP2C19*2 homozygotes at time of clopidigrel prescribing). A few tens of bytes each. Layered classes of EHR-relevant data Interpretive codes Diagnostic Interpretations (PDF reports). A few kilobytes each. Personal molecular differences represented in EHR as computed offset from a Clinical Standard Reference Genome (CSRG) =~1% of genome/ proteome. A few megabytes. Consensus full personal germline and somatic sequence(s) and metadata: a few gigabytes each 8x -30x nextgen reads: hundreds of gigabytes/terabyte